Xtant Medical Holdings (XTNT) Finished Goods (2019 - 2025)

Xtant Medical Holdings (XTNT) has 7 years of Finished Goods data on file, last reported at $19.8 million in Q4 2025.

• On a quarterly basis, Finished Goods fell 32.28% year-over-year to $19.8 million in Q4 2025; TTM through Dec 2025 was $19.8 million, a 32.28% decrease from a year earlier, with the FY2025 full-year figure at $19.8 million, down 32.28% from the prior year.
• Finished Goods for Q4 2025 stood at $19.8 million, down from $30.6 million in the prior quarter.
• Over the last five years, Finished Goods for XTNT reached as high as $31.9 million in Q3 2024 and fell as low as $10.6 million in Q2 2022.
• Historically, Finished Goods has averaged $20.6 million across 5 years, with a median of $18.1 million in 2021.
• Across the five-year window, Finished Goods soared 158.62% in 2024 and slumped 32.28% in 2025, its largest moves.
• Year by year, Finished Goods stood at $11.8 million in 2021, then slipped by 7.67% to $10.9 million in 2022, then jumped by 158.35% to $28.1 million in 2023, then rose by 4.08% to $29.2 million in 2024, then slumped by 32.28% to $19.8 million in 2025.
• Per Business Quant data, the three most recent Finished Goods figures were $19.8 million in Q4 2025, $30.6 million in Q3 2025, and $31.2 million in Q2 2025.